ALCOHOL

ALCOHOL was reported 38844 times

ALCOHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 120 0.5240
1 BLOOD ETHANOL 21 0.5000
2 EX-DRUG ABUSER 13 0.4815
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 268 0.4012
4 LUPUS VULGARIS 469 0.3722
5 POSTMORTEM BLOOD DRUG LEVEL 21 0.3559
6 ALCOHOL INTERACTION 615 0.3162
7 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 169 0.3012
8 SWOLLEN JOINT COUNT 74 0.2960
9 VICTIM OF CRIME 357 0.2886
10 ALCOHOL TEST POSITIVE 13 0.2766
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 537 0.2681
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 533 0.2570
13 SWOLLEN JOINT COUNT INCREASED 814 0.2550
14 BLOOD ETHANOL INCREASED 55 0.2500
15 RHEUMATIC FEVER 1112 0.2492
16 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 36 0.2449
17 C-REACTIVE PROTEIN 224 0.2416
18 CHEMICAL SUBMISSION 59 0.2332
19 DISLOCATION OF VERTEBRA 516 0.2260
20 FACET JOINT SYNDROME 731 0.2243
21 X-RAY ABNORMAL 401 0.2240
22 BEHAVIOURAL ADDICTION 14 0.2222
23 HEPATIC ENZYME 32 0.2148
24 ALCOHOL POISONING 572 0.2134
25 ACQUIRED PORPHYRIA 15 0.2113
26 BLOOD ALCOHOL INCREASED 164 0.2095
27 ALCOHOL ABUSE 535 0.1999
28 RETINITIS 327 0.1891
29 DUODENAL ULCER PERFORATION 1365 0.1834
30 FOETAL ALCOHOL SYNDROME 18 0.1800
31 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1206 0.1682
32 RHEUMATOID FACTOR POSITIVE 964 0.1667
33 MUSCLE INJURY 1264 0.1524
34 PORPHYRIA ACUTE 214 0.1491
35 POLYSUBSTANCE DEPENDENCE 25 0.1462
36 HELICOBACTER INFECTION 1471 0.1430
37 SUBSTANCE USE DISORDER 440 0.1380
38 FOLLICULITIS 1440 0.1372
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 882 0.1357
40 SUSPECTED SUICIDE 608 0.1296
41 PERIPHERAL VENOUS DISEASE 520 0.1272
42 SUBSTANCE DEPENDENCE 85 0.1263
43 ENVIRONMENTAL EXPOSURE 30 0.1255
44 C-REACTIVE PROTEIN ABNORMAL 773 0.1204
45 PEMPHIGUS 1495 0.1195
46 VICTIM OF SEXUAL ABUSE 62 0.1179
47 HAND DEFORMITY 1473 0.1122
48 SUBSTANCE ABUSE 899 0.1103
49 ALCOHOL USE 402 0.1088
50 EXPOSURE TO TOXIC AGENT 336 0.1049
51 EXPOSURE VIA INGESTION 261 0.1034
52 BONE EROSION 359 0.1014
53 ALCOHOLIC 20 0.1005
54 ILLICIT PRESCRIPTION ATTAINMENT 12 0.1000
55 COMPLETED SUICIDE 8255 0.0990
56 SERONEGATIVE ARTHRITIS 106 0.0925
57 ALCOHOL WITHDRAWAL SYNDROME 80 0.0920
58 BREAST CANCER STAGE III 591 0.0912
59 PERICARDITIS 1458 0.0867
60 DRUG ABUSE 7012 0.0841
61 MULTIPLE DRUG OVERDOSE INTENTIONAL 270 0.0839
62 ALCOHOL USE DISORDER 14 0.0819
63 LIP DRY 743 0.0817
64 HANGING 16 0.0808
65 HOMICIDE 146 0.0792
66 HYPERCHOLESTEROLAEMIA 761 0.0787
67 POISONING 985 0.0783
68 ACCIDENTAL DEATH 143 0.0769
69 SYNOVITIS 1385 0.0767
70 ONYCHOMADESIS 318 0.0757
71 GRIP STRENGTH DECREASED 662 0.0751
72 POSTMORTEM BLOOD DRUG LEVEL INCREASED 28 0.0751
73 ADULTERATED PRODUCT 15 0.0750
74 JOINT RANGE OF MOTION DECREASED 1006 0.0749
75 SUBSTANCE ABUSER 17 0.0749
76 ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0748
77 CHILD NEGLECT 18 0.0747
78 OPIATES POSITIVE 35 0.0729
79 TOXICOLOGIC TEST ABNORMAL 44 0.0726
80 VICTIM OF HOMICIDE 41 0.0704
81 IRRITABLE BOWEL SYNDROME 1473 0.0686
82 SEXUAL ABUSE 30 0.0677
83 ONYCHOMYCOSIS 294 0.0669
84 GLOSSODYNIA 1494 0.0667
85 ALCOHOL INTOLERANCE 47 0.0662
86 ALCOHOL PROBLEM 16 0.0653
87 WOUND INFECTION 710 0.0648
88 HYPOCHOLESTEROLAEMIA 21 0.0595
89 VICTIM OF CHEMICAL SUBMISSION 39 0.0581
90 CONGESTIVE HEPATOPATHY 26 0.0580
91 BREATH ALCOHOL TEST POSITIVE 13 0.0578
92 DRUG USE DISORDER 484 0.0575
93 ALCOHOLIC PANCREATITIS 11 0.0564
94 DRUG TOLERANCE DECREASED 158 0.0562
95 SLEEP WALKING 31 0.0538
96 ALCOHOLIC LIVER DISEASE 18 0.0531
97 MULTIPLE DRUG OVERDOSE 263 0.0529
98 BURSITIS 637 0.0524
99 AUTOIMMUNE DISORDER 509 0.0522
100 WOUND 1459 0.0521
101 CARDIO-RESPIRATORY ARREST 2155 0.0515
102 VISCERAL CONGESTION 26 0.0509
103 PUSTULAR PSORIASIS 173 0.0503
104 DELIRIUM TREMENS 20 0.0495
105 TOXICITY TO VARIOUS AGENTS 7888 0.0467
106 LIVER INJURY 1147 0.0467
107 RESPIRATORY ARREST 1286 0.0466
108 FIBROMYALGIA 1129 0.0464
109 CHILD ABUSE 12 0.0463
110 INTENTIONAL MISUSE 88 0.0460
111 WALKING AID USER 301 0.0456
112 POISONING DELIBERATE 429 0.0452
113 IMPAIRED HEALING 1465 0.0446
114 MATERNAL EXPOSURE TIMING UNSPECIFIED 167 0.0444
115 MULTIPLE DRUG OVERDOSE ACCIDENTAL 20 0.0438
116 HEPATITIS ALCOHOLIC 14 0.0428
117 SYSTEMIC LUPUS ERYTHEMATOSUS 1470 0.0414
118 PHYSICAL ASSAULT 85 0.0407
119 FINGER DEFORMITY 195 0.0402
120 LIVE BIRTH 336 0.0401
121 CIRRHOSIS ALCOHOLIC 18 0.0393
122 EXOSTOSIS 353 0.0386
123 EYE INJURY 117 0.0385
124 BLEPHAROSPASM 242 0.0384
125 TYPE 2 DIABETES MELLITUS 1280 0.0380
126 STAB WOUND 13 0.0367
127 LUPUS-LIKE SYNDROME 333 0.0367
128 ALCOHOLISM 157 0.0366
129 DRUG TOXICITY 493 0.0362
130 OBESITY 566 0.0355
131 ULCER HAEMORRHAGE 240 0.0354
132 CONGENITAL UMBILICAL HERNIA 13 0.0349
133 SCIATICA 550 0.0345
134 RASH VESICULAR 166 0.0343
135 CONTRAINDICATED PRODUCT ADMINISTERED 1036 0.0342
136 PULMONARY FIBROSIS 655 0.0341
137 GUN SHOT WOUND 64 0.0337
138 NAIL DISORDER 294 0.0336
139 DETOXIFICATION 11 0.0318
140 INTENTIONAL OVERDOSE 1977 0.0308
141 ASPHYXIA 249 0.0305
142 DRUG SCREEN POSITIVE 240 0.0303
143 LEGAL PROBLEM 22 0.0299
144 PSORIATIC ARTHROPATHY 1211 0.0298
145 SELF INJURIOUS BEHAVIOUR 91 0.0298
146 MYOCARDIAL FIBROSIS 25 0.0298
147 LOWER LIMB FRACTURE 554 0.0288
148 OVERLAP SYNDROME 20 0.0286
149 BRADYPNOEA 77 0.0285
150 SUSPECTED SUICIDE ATTEMPT 17 0.0285
151 MIOSIS 227 0.0283
152 FOOT DEFORMITY 312 0.0281
153 DRUG DETOXIFICATION 25 0.0280
154 RED BLOOD CELL SEDIMENTATION RATE INCREASED 307 0.0277
155 LOWER RESPIRATORY TRACT INFECTION 1251 0.0275
156 PRESCRIBED OVERDOSE 518 0.0267
157 AMPHETAMINES POSITIVE 20 0.0267
158 DROWNING 27 0.0267
159 IMPAIRED DRIVING ABILITY 299 0.0263
160 SUICIDE ATTEMPT 1588 0.0262
161 ROAD TRAFFIC ACCIDENT 1081 0.0258
162 JOINT DISLOCATION 273 0.0258
163 HIP ARTHROPLASTY 392 0.0256
164 BREAST CANCER STAGE II 208 0.0250
165 PRODUCT LABEL CONFUSION 145 0.0249
166 ACCIDENTAL POISONING 34 0.0248
167 HEPATIC CIRRHOSIS 461 0.0245
168 INTENTIONAL DRUG MISUSE 509 0.0243
169 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 124 0.0242
170 SENSORIMOTOR DISORDER 12 0.0241
171 THEFT 16 0.0241
172 ANALGESIC DRUG LEVEL INCREASED 38 0.0237
173 PUPIL FIXED 41 0.0236
174 RESPIRATORY DEPRESSION 288 0.0235
175 ANOXIC ENCEPHALOPATHY 15 0.0233
176 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 18 0.0231
177 GAIT INABILITY 769 0.0230
178 BLISTER 1287 0.0229
179 ARTHROPATHY 1271 0.0228
180 BLOOD CHOLESTEROL INCREASED 1056 0.0226
181 HEPATIC ENZYME INCREASED 1518 0.0222
182 ANION GAP 14 0.0221
183 INFUSION RELATED REACTION 1463 0.0221
184 ILL-DEFINED DISORDER 1310 0.0215
185 JUDGEMENT IMPAIRED 31 0.0213
186 COMA 1003 0.0210
187 BACK INJURY 229 0.0210
188 CONGENITAL ANOMALY 163 0.0210
189 BEZOAR 29 0.0210
190 HYPERLIPASAEMIA 11 0.0210
191 INJURY 1476 0.0210
192 STOMATITIS 1267 0.0209
193 GRIEF REACTION 11 0.0208
194 CARDIAC DEATH 25 0.0207
195 GENERAL SYMPTOM 155 0.0207
196 MYDRIASIS 264 0.0206
197 SUBSTANCE USE 32 0.0205
198 AREFLEXIA 54 0.0202
199 NIGHT SWEATS 647 0.0201
200 DELIRIUM 693 0.0199
201 DRUG DIVERSION 122 0.0197
202 COMA SCALE ABNORMAL 57 0.0197
203 PRESCRIBED UNDERDOSE 391 0.0196
204 SPONDYLITIS 71 0.0195
205 PARASOMNIA 14 0.0195
206 DISCOMFORT 1184 0.0194
207 CARDIAC ARREST 1600 0.0194
208 DISINHIBITION 31 0.0192
209 COUNTERFEIT PRODUCT ADMINISTERED 25 0.0192
210 MYOSITIS 172 0.0191
211 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 117 0.0189
212 CARDIAC HYPERTROPHY 21 0.0188
213 THERAPEUTIC PRODUCT EFFECT DECREASED 836 0.0186
214 SLEEP DISORDER 1310 0.0185
215 PRODUCT ADMINISTRATION INTERRUPTED 142 0.0181
216 OSTEOARTHRITIS 761 0.0179
217 POTENTIATING DRUG INTERACTION 60 0.0179
218 BRAIN DEATH 55 0.0178
219 WHEEZING 1052 0.0177
220 IMPRISONMENT 31 0.0175
221 KNEE ARTHROPLASTY 367 0.0174
222 AMNESIA 1134 0.0174
223 PERFORATION 14 0.0174
224 SLEEP-RELATED EATING DISORDER 16 0.0171
225 COELIAC DISEASE 166 0.0169
226 SOMNAMBULISM 111 0.0169
227 RESPIRATORY ACIDOSIS 66 0.0168
228 OEDEMA 883 0.0163
229 DRUG ABUSER 99 0.0161
230 NON-CARDIOGENIC PULMONARY OEDEMA 17 0.0161
231 FEELING OF RELAXATION 11 0.0161
232 C-REACTIVE PROTEIN INCREASED 580 0.0159
233 BLOOD PH DECREASED 27 0.0158
234 SPINAL FUSION SURGERY 64 0.0158
235 LIVER DISORDER 698 0.0157
236 ANION GAP INCREASED 21 0.0157
237 MOBILITY DECREASED 1118 0.0155
238 ABNORMAL SLEEP-RELATED EVENT 20 0.0151
239 EUPHORIC MOOD 155 0.0151
240 SWELLING 1411 0.0151
241 LIVER FUNCTION TEST INCREASED 321 0.0149
242 DRUG-INDUCED LIVER INJURY 453 0.0144
243 DISABILITY 279 0.0141
244 BEHAVIOUR DISORDER 76 0.0140
245 INFLAMMATION 721 0.0140
246 SOPOR 185 0.0139
247 NORMAL NEWBORN 75 0.0138
248 HEPATIC CONGESTION 13 0.0137
249 ALLERGY TO CHEMICALS 17 0.0136
250 HYPOTHERMIA 138 0.0136
251 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 233 0.0136
252 ACIDOSIS 103 0.0135
253 LUNG DISORDER 654 0.0133
254 HYPOPERFUSION 14 0.0133
255 ADVERSE REACTION 176 0.0133
256 HEPATIC NECROSIS 50 0.0133
257 ASPIRATION 145 0.0132
258 PULSELESS ELECTRICAL ACTIVITY 55 0.0131
259 FOAMING AT MOUTH 26 0.0129
260 PILOERECTION 14 0.0128
261 AGGRESSION 640 0.0128
262 INTENTIONAL PRODUCT USE ISSUE 1116 0.0127
263 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 42 0.0127
264 BRAIN OEDEMA 159 0.0126
265 DEREALISATION 27 0.0125
266 SUICIDAL BEHAVIOUR 52 0.0125
267 JOINT SWELLING 1497 0.0124
268 ARTERIOSCLEROSIS CORONARY ARTERY 82 0.0124
269 RHEUMATOID ARTHRITIS 1393 0.0123
270 NYSTAGMUS 65 0.0122
271 HEPATIC FIBROSIS 42 0.0122
272 GASTROINTESTINAL DISORDER 1096 0.0122
273 BRAIN HYPOXIA 12 0.0119
274 ACUTE HEPATIC FAILURE 163 0.0119
275 DISTRIBUTIVE SHOCK 27 0.0119
276 INTENTIONAL SELF-INJURY 240 0.0119
277 MUSCULOSKELETAL PAIN 620 0.0118
278 PSYCHOTIC BEHAVIOUR 12 0.0118
279 INTENTIONAL PRODUCT MISUSE 1029 0.0117
280 GENERAL PHYSICAL HEALTH DETERIORATION 1355 0.0117
281 UNRESPONSIVE TO STIMULI 302 0.0117
282 MUSCULOSKELETAL STIFFNESS 1023 0.0117
283 JOINT STIFFNESS 306 0.0117
284 BLOOD BICARBONATE DECREASED 22 0.0116
285 CONTUSION 1118 0.0116
286 EAR INFECTION 308 0.0116
287 CONSCIOUSNESS FLUCTUATING 12 0.0115
288 COMPARTMENT SYNDROME 30 0.0115
289 PREGNANCY 230 0.0115
290 OVERDOSE 2461 0.0114
291 TASTE DISORDER 230 0.0113
292 CONFUSIONAL STATE 1821 0.0113
293 DRUG TOLERANCE 57 0.0113
294 SINUSITIS 1152 0.0112
295 SINUS TACHYCARDIA 156 0.0110
296 DEPRESSED LEVEL OF CONSCIOUSNESS 428 0.0108
297 ANTICHOLINERGIC SYNDROME 17 0.0107
298 TOOTH EROSION 13 0.0106
299 BACK DISORDER 172 0.0106
300 MATERNAL EXPOSURE DURING PREGNANCY 941 0.0105
301 TEARFULNESS 45 0.0105
302 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 176 0.0104
303 MACROCYTOSIS 12 0.0103
304 HYPERREFLEXIA 36 0.0103
305 NEOPLASM SKIN 16 0.0103
306 HEPATIC ENCEPHALOPATHY 96 0.0103
307 DRUG INTOLERANCE 992 0.0103
308 SELF-MEDICATION 42 0.0102
309 GASTRIC DILATATION 17 0.0102
310 DRY MOUTH 826 0.0102
311 ALTERED STATE OF CONSCIOUSNESS 220 0.0101
312 BLADDER DILATATION 11 0.0101
313 CELL DEATH 20 0.0101
314 BLOOD LACTIC ACID INCREASED 53 0.0101
315 INFUSION SITE REACTION 30 0.0100
316 PULMONARY CONGESTION 131 0.0099
317 MEDICATION ERROR 552 0.0099
318 PERSONALITY DISORDER 26 0.0099
319 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 26 0.0099
320 PSYCHOMOTOR SKILLS IMPAIRED 26 0.0099
321 RESPIRATORY RATE DECREASED 31 0.0099
322 SKULL FRACTURE 16 0.0099
323 DRUG LEVEL INCREASED 163 0.0098
324 EPILEPSY 301 0.0098
325 GRAND MAL CONVULSION 90 0.0097
326 HYPOVENTILATION 31 0.0095
327 TACHYCARDIA 842 0.0095
328 METABOLIC ACIDOSIS 302 0.0094
329 HEPATITIS 241 0.0094
330 TREATMENT FAILURE 775 0.0093
331 PRODUCT COUNTERFEIT 16 0.0093
332 HYPERTENSIVE HEART DISEASE 17 0.0091
333 LOGORRHOEA 32 0.0091
334 STUPOR 29 0.0090
335 HYPERLACTACIDAEMIA 24 0.0089
336 THERAPY NON-RESPONDER 402 0.0089
337 HEPATORENAL SYNDROME 15 0.0089
338 INFECTION 1284 0.0089
339 ARTERIOSCLEROSIS 83 0.0088
340 HANGOVER 31 0.0088
341 WEIGHT FLUCTUATION 92 0.0088
342 AGITATION 641 0.0087
343 DYSPEPSIA 857 0.0087
344 PNEUMONIA ASPIRATION 217 0.0087
345 PUPILLARY REFLEX IMPAIRED 16 0.0086
346 INTELLECTUAL DISABILITY 13 0.0086
347 TONIC CONVULSION 12 0.0085
348 HOMICIDAL IDEATION 34 0.0084
349 BRAIN HERNIATION 25 0.0084
350 EXTRADURAL HAEMATOMA 11 0.0083
351 LABELLED DRUG-DRUG INTERACTION ISSUE 12 0.0083
352 ANTIPSYCHOTIC DRUG LEVEL INCREASED 23 0.0082
353 GENERALISED ANXIETY DISORDER 12 0.0082
354 FREQUENT BOWEL MOVEMENTS 220 0.0081
355 ACCIDENTAL OVERDOSE 296 0.0081
356 HYPERSENSITIVITY 1495 0.0080
357 SHOCK 185 0.0080
358 ABDOMINAL DISCOMFORT 1344 0.0080
359 RESPIRATORY ALKALOSIS 13 0.0080
360 OSTEOPOROSIS 326 0.0079
361 ELECTROCARDIOGRAM QT PROLONGED 284 0.0079
362 MIGRAINE 753 0.0079
363 EXCORIATION 20 0.0079
364 PERIPHERAL SWELLING 1211 0.0079
365 BREATH ODOUR 19 0.0078
366 SEROTONIN SYNDROME 149 0.0077
367 PULMONARY OEDEMA 342 0.0076
368 VENTRICULAR HYPERTROPHY 19 0.0076
369 INCOHERENT 49 0.0076
370 HYPOAESTHESIA 1131 0.0075
371 HAEMODYNAMIC INSTABILITY 57 0.0075
372 HOSTILITY 19 0.0075
373 PSYCHOMOTOR RETARDATION 21 0.0075
374 SEDATION COMPLICATION 19 0.0074
375 SOCIAL AVOIDANT BEHAVIOUR 43 0.0074
376 DYSARTHRIA 279 0.0074
377 HEPATIC STEATOSIS 138 0.0074
378 PROTHROMBIN TIME PROLONGED 44 0.0073
379 BRADYARRHYTHMIA 12 0.0073
380 NASOPHARYNGITIS 1340 0.0073
381 CARDIOGENIC SHOCK 104 0.0072
382 PERSECUTORY DELUSION 18 0.0072
383 DISTURBANCE IN SOCIAL BEHAVIOUR 17 0.0072
384 HYPERTRANSAMINASAEMIA 50 0.0072
385 PSYCHIATRIC DECOMPENSATION 14 0.0072
386 EXPOSURE DURING PREGNANCY 445 0.0072
387 RENAL TUBULAR NECROSIS 70 0.0071
388 SLOW SPEECH 17 0.0070
389 ABNORMAL BEHAVIOUR 275 0.0069
390 IMPULSIVE BEHAVIOUR 26 0.0069
391 ALOPECIA 1355 0.0069
392 PRE-EXISTING CONDITION IMPROVED 43 0.0069
393 MEMORY IMPAIRMENT 943 0.0069
394 URTICARIA 1148 0.0068
395 HEPATIC FAILURE 206 0.0068
396 FOOD INTERACTION 12 0.0068
397 IMPULSE-CONTROL DISORDER 14 0.0068
398 HYPOREFLEXIA 13 0.0068
399 INTERNATIONAL NORMALISED RATIO FLUCTUATION 14 0.0068
400 HYPERTENSION 1428 0.0067
401 MYOCARDITIS 77 0.0067
402 SUDDEN DEATH 71 0.0067
403 SELF-INJURIOUS IDEATION 28 0.0067
404 DRUG INTERACTION 1050 0.0066
405 CLONUS 18 0.0066
406 VENTRICULAR ARRHYTHMIA 24 0.0066
407 APNOEA 51 0.0065
408 DRUG LEVEL ABOVE THERAPEUTIC 30 0.0065
409 CONDUCTION DISORDER 12 0.0065
410 LEFT VENTRICULAR HYPERTROPHY 28 0.0065
411 CEREBELLAR INFARCTION 11 0.0065
412 SUICIDAL IDEATION 595 0.0065
413 DRUG WITHDRAWAL SYNDROME NEONATAL 96 0.0065
414 MAJOR DEPRESSION 47 0.0064
415 LIBIDO INCREASED 13 0.0064
416 BLOOD CHLORIDE INCREASED 11 0.0064
417 INTERVERTEBRAL DISCITIS 12 0.0064
418 PARANOIA 109 0.0063
419 LOSS OF CONSCIOUSNESS 810 0.0063
420 BRAIN INJURY 63 0.0063
421 WEIGHT INCREASED 1403 0.0063
422 CARDIOMEGALY 76 0.0062
423 EYE CONTUSION 13 0.0061
424 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 288 0.0060
425 POST-TRAUMATIC STRESS DISORDER 40 0.0060
426 CRANIOCEREBRAL INJURY 18 0.0059
427 CEREBELLAR SYNDROME 13 0.0059
428 DRUG DEPENDENCE 952 0.0059
429 RESPIRATORY DISORDER 175 0.0058
430 WHITE BLOOD CELL COUNT INCREASED 223 0.0058
431 ENCEPHALOPATHY 140 0.0057
432 PULSE ABSENT 27 0.0057
433 RHABDOMYOLYSIS 235 0.0056
434 HEPATOMEGALY 55 0.0056
435 FEELING DRUNK 41 0.0055
436 FUNCTIONAL GASTROINTESTINAL DISORDER 19 0.0055
437 HYPOPNOEA 19 0.0055
438 ASTHMA 616 0.0054
439 SOMNOLENCE 1091 0.0054
440 COAGULOPATHY 90 0.0054
441 RECTAL HAEMORRHAGE 232 0.0054
442 MULTIPLE INJURIES 34 0.0054
443 CARDIOPULMONARY FAILURE 21 0.0054
444 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 12 0.0054
445 HEPATOTOXICITY 118 0.0053
446 SNORING 20 0.0053
447 ACCIDENTAL EXPOSURE 22 0.0053
448 ACCIDENT 63 0.0053
449 VENTRICULAR TACHYCARDIA 87 0.0053
450 RESTLESSNESS 192 0.0052
451 PULMONARY HAEMORRHAGE 41 0.0052
452 PANCREATITIS 277 0.0052
453 CIRCULATORY COLLAPSE 89 0.0052
454 LABORATORY TEST ABNORMAL 154 0.0052
455 ENURESIS 21 0.0052
456 TACHYPHRENIA 18 0.0052
457 GENERALISED TONIC-CLONIC SEIZURE 86 0.0052
458 COLITIS ULCERATIVE 232 0.0052
459 DEPRESSION 1170 0.0051
460 CLUMSINESS 14 0.0051
461 OEDEMA PERIPHERAL 625 0.0051
462 INSOMNIA 1362 0.0051
463 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22 0.0051
464 VENTRICULAR FIBRILLATION 56 0.0050
465 MYOCLONUS 60 0.0050
466 SCREAMING 32 0.0050
467 CYANOSIS 79 0.0050
468 MENTAL STATUS CHANGES 138 0.0050
469 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0050
470 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
471 ADVERSE EVENT 452 0.0049
472 LEUKOENCEPHALOPATHY 18 0.0048
473 DRUG WITHDRAWAL SYNDROME 421 0.0048
474 ABDOMINAL PAIN UPPER 980 0.0048
475 FLAT AFFECT 11 0.0047
476 CHEST PAIN 876 0.0047
477 FACIAL BONES FRACTURE 17 0.0047
478 HYPERTONIA 27 0.0047
479 INTENTIONAL DOSE OMISSION 134 0.0047
480 BRONCHOPNEUMONIA 16 0.0047
481 ENDOTRACHEAL INTUBATION 13 0.0046
482 WITHDRAWAL SYNDROME 192 0.0046
483 DISORIENTATION 181 0.0046
484 MUSCLE SPASTICITY 56 0.0046
485 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 321 0.0045
486 OLIGURIA 28 0.0045
487 THERAPEUTIC AGENT TOXICITY 15 0.0045
488 EAR PAIN 87 0.0045
489 ACUTE PULMONARY OEDEMA 25 0.0044
490 LACTIC ACIDOSIS 144 0.0044
491 ARTHRITIS 347 0.0044
492 MUSCULAR WEAKNESS 500 0.0044
493 SOCIAL PROBLEM 18 0.0043
494 PRODUCT USE ISSUE 812 0.0043
495 SLUGGISHNESS 44 0.0043
496 PSYCHOTIC DISORDER 127 0.0043
497 PSYCHOMOTOR HYPERACTIVITY 71 0.0043
498 PARAESTHESIA 670 0.0043
499 CONDITION AGGRAVATED 1286 0.0042
500 LYME DISEASE 14 0.0042
501 HYPERTHERMIA 32 0.0042
502 UPPER RESPIRATORY TRACT INFECTION 192 0.0042
503 NECK PAIN 231 0.0041
504 ATAXIA 49 0.0041
505 FEELING HOT 253 0.0041
506 BREAST CANCER STAGE I 38 0.0041
507 HAEMODIALYSIS 34 0.0040
508 PARTIAL SEIZURES 21 0.0040
509 PERSONALITY CHANGE 37 0.0040
510 APATHY 58 0.0040
511 DEPRESSIVE SYMPTOM 14 0.0040
512 HYPOTENSION 792 0.0039
513 VOMITING 1855 0.0039
514 MUSCLE SPASMS 717 0.0039
515 CONVULSION 223 0.0039
516 ADVERSE DRUG REACTION 350 0.0039
517 SEDATION 102 0.0039
518 GAIT DISTURBANCE 744 0.0039
519 BIPOLAR DISORDER 42 0.0039
520 FEELING OF DESPAIR 18 0.0039
521 HEPATITIS ACUTE 25 0.0038
522 HYPOMANIA 14 0.0038
523 HYPOXIA 134 0.0038
524 DECREASED APPETITE 881 0.0038
525 GASTROOESOPHAGEAL REFLUX DISEASE 305 0.0038
526 DISSOCIATION 29 0.0038
527 INJECTION SITE REACTION 258 0.0037
528 FLUID RETENTION 190 0.0037
529 PYREXIA 1259 0.0036
530 HYPOGLYCAEMIA 176 0.0036
531 ANXIETY 1028 0.0036
532 DELUSION 56 0.0036
533 MANIA 59 0.0036
534 RASH 1552 0.0036
535 STATUS EPILEPTICUS 40 0.0035
536 BRADYPHRENIA 23 0.0035
537 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
538 BUNDLE BRANCH BLOCK RIGHT 16 0.0035
539 RESPIRATION ABNORMAL 24 0.0035
540 PRODUCT USE IN UNAPPROVED INDICATION 859 0.0035
541 CARDIAC FAILURE ACUTE 23 0.0034
542 MULTIPLE ORGAN DYSFUNCTION SYNDROME 97 0.0034
543 TRANSAMINASES INCREASED 76 0.0034
544 DEATH 2931 0.0034
545 BRADYKINESIA 20 0.0034
546 RESPIRATORY RATE INCREASED 30 0.0034
547 EMPHYSEMA 34 0.0034
548 HALLUCINATION, AUDITORY 53 0.0033
549 ACUTE RESPIRATORY FAILURE 64 0.0033
550 PANIC REACTION 24 0.0033
551 ATTENTION DEFICIT HYPERACTIVITY DISORDER 14 0.0033
552 SEIZURE 383 0.0033
553 PRURITUS 1272 0.0033
554 BUNDLE BRANCH BLOCK LEFT 14 0.0033
555 THINKING ABNORMAL 61 0.0033
556 ARTHRALGIA 1346 0.0032
557 GASTRITIS EROSIVE 15 0.0032
558 HYPERAMMONAEMIA 16 0.0032
559 DISSEMINATED INTRAVASCULAR COAGULATION 45 0.0032
560 FOETAL EXPOSURE DURING PREGNANCY 259 0.0032
561 PAIN IN EXTREMITY 937 0.0032
562 TACHYPNOEA 43 0.0032
563 SUBARACHNOID HAEMORRHAGE 32 0.0031
564 AMMONIA INCREASED 16 0.0031
565 MULTI-ORGAN FAILURE 54 0.0031
566 VISUAL IMPAIRMENT 387 0.0031
567 GAMMA-GLUTAMYLTRANSFERASE INCREASED 69 0.0031
568 IRON DEFICIENCY 14 0.0031
569 HYPERVENTILATION 18 0.0031
570 PNEUMONIA 1005 0.0031
571 SALIVARY HYPERSECRETION 31 0.0031
572 MENTAL IMPAIRMENT 75 0.0031
573 HALLUCINATIONS, MIXED 13 0.0031
574 HALLUCINATION, VISUAL 65 0.0031
575 THERAPEUTIC RESPONSE DECREASED 186 0.0031
576 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
577 INTRACRANIAL PRESSURE INCREASED 17 0.0030
578 ALANINE AMINOTRANSFERASE INCREASED 187 0.0030
579 HEAD INJURY 96 0.0030
580 ASPARTATE AMINOTRANSFERASE INCREASED 161 0.0030
581 INTENTIONAL UNDERDOSE 22 0.0030
582 DEVELOPMENTAL DELAY 27 0.0030
583 MYOCARDIAL ISCHAEMIA 34 0.0030
584 TREATMENT NONCOMPLIANCE 163 0.0030
585 CONCUSSION 23 0.0030
586 DRUG ADMINISTRATION ERROR 91 0.0030
587 THERMAL BURN 21 0.0030
588 TENSION 18 0.0030
589 HYPOKALAEMIA 135 0.0029
590 AFFECT LABILITY 28 0.0029
591 ANGER 98 0.0029
592 DEPRESSED MOOD 153 0.0029
593 DECREASED INTEREST 17 0.0029
594 FORMICATION 20 0.0029
595 BLOOD PRESSURE SYSTOLIC DECREASED 13 0.0029
596 HAEMOLYSIS 22 0.0028
597 LIVER FUNCTION TEST ABNORMAL 82 0.0028
598 LETHARGY 162 0.0028
599 UNDERDOSE 205 0.0028
600 ATELECTASIS 27 0.0028
601 BRADYCARDIA 148 0.0028
602 METABOLIC DISORDER 16 0.0028
603 ELECTROLYTE IMBALANCE 32 0.0028
604 BODY TEMPERATURE INCREASED 56 0.0027
605 PAIN 1680 0.0027
606 HEPATITIS C 33 0.0027
607 COORDINATION ABNORMAL 38 0.0027
608 PRODUCT ADMINISTRATION ERROR 55 0.0027
609 ABNORMAL DREAMS 75 0.0027
610 DYSPNOEA 1536 0.0027
611 LEUKOCYTOSIS 49 0.0027
612 HYPOTONIA 27 0.0027
613 PSORIASIS 350 0.0027
614 AFFECTIVE DISORDER 21 0.0027
615 HEPATIC CYTOLYSIS 34 0.0027
616 MALAISE 1163 0.0026
617 WEIGHT DECREASED 737 0.0026
618 CONGESTIVE CARDIOMYOPATHY 11 0.0026
619 SCHIZOPHRENIA 32 0.0026
620 GASTROINTESTINAL SOUNDS ABNORMAL 13 0.0026
621 HALLUCINATION 197 0.0026
622 NIGHTMARE 90 0.0026
623 SKIN LACERATION 28 0.0026
624 TOXIC ENCEPHALOPATHY 13 0.0026
625 AKATHISIA 35 0.0026
626 ABDOMINAL PAIN 595 0.0026
627 ANURIA 22 0.0026
628 PETIT MAL EPILEPSY 13 0.0025
629 ENERGY INCREASED 15 0.0025
630 EJECTION FRACTION DECREASED 39 0.0025
631 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
632 MENTAL DISORDER 108 0.0025
633 ABDOMINAL DISTENSION 259 0.0025
634 TORSADE DE POINTES 19 0.0024
635 ABDOMINAL TENDERNESS 12 0.0024
636 PAPULE 17 0.0024
637 BRUXISM 13 0.0024
638 SLEEP APNOEA SYNDROME 46 0.0024
639 CORONARY ARTERY STENOSIS 12 0.0024
640 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
641 BRONCHITIS 173 0.0023
642 INCORRECT ROUTE OF DRUG ADMINISTRATION 83 0.0023
643 ARRHYTHMIA 109 0.0023
644 DIZZINESS 1145 0.0023
645 OXYGEN SATURATION DECREASED 128 0.0023
646 POLYARTHRITIS 12 0.0023
647 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
648 DRUG EXPOSURE DURING PREGNANCY 77 0.0023
649 HAEMATEMESIS 57 0.0022
650 BLOOD BILIRUBIN INCREASED 60 0.0022
651 FATIGUE 1712 0.0022
652 POLYURIA 18 0.0022
653 FACE OEDEMA 37 0.0022
654 IRRITABILITY 131 0.0022
655 SINUS BRADYCARDIA 21 0.0022
656 DISTURBANCE IN ATTENTION 117 0.0022
657 HEADACHE 1358 0.0022
658 ASTHENIA 810 0.0022
659 FOETAL GROWTH RESTRICTION 13 0.0021
660 MOOD SWINGS 68 0.0021
661 CARDIOTOXICITY 19 0.0021
662 LACERATION 20 0.0021
663 DUODENAL ULCER 15 0.0021
664 MUSCLE TWITCHING 49 0.0021
665 ANOREXIA 27 0.0021
666 RESTLESS LEGS SYNDROME 38 0.0021
667 RENAL FAILURE ACUTE 88 0.0021
668 HYPOKINESIA 30 0.0021
669 NAUSEA 1629 0.0021
670 NEUTROPHIL COUNT INCREASED 21 0.0020
671 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
672 RESPIRATORY FAILURE 149 0.0020
673 PANCREATITIS ACUTE 45 0.0020
674 COGNITIVE DISORDER 93 0.0020
675 RASH PRURITIC 107 0.0020
676 RESPIRATORY DISTRESS 54 0.0020
677 EMOTIONAL DISORDER 60 0.0019
678 NEUROLEPTIC MALIGNANT SYNDROME 23 0.0019
679 BODY TEMPERATURE DECREASED 19 0.0019
680 PSYCHIATRIC SYMPTOM 14 0.0019
681 NERVOUS SYSTEM DISORDER 59 0.0019
682 OBSTRUCTIVE AIRWAYS DISORDER 21 0.0019
683 MOOD ALTERED 51 0.0019
684 ACUTE KIDNEY INJURY 286 0.0019
685 PANIC ATTACK 68 0.0019
686 MOTOR DYSFUNCTION 19 0.0019
687 POOR QUALITY SLEEP 40 0.0019
688 DERMATITIS CONTACT 21 0.0018
689 HYPERBILIRUBINAEMIA 19 0.0018
690 MIDDLE INSOMNIA 34 0.0018
691 TREMOR 302 0.0018
692 CRYING 66 0.0018
693 SEXUAL DYSFUNCTION 21 0.0018
694 PRODUCT QUALITY ISSUE 243 0.0018
695 HYPERHIDROSIS 230 0.0018
696 DIARRHOEA 1149 0.0018
697 ANAL INCONTINENCE 16 0.0018
698 HYPERLIPIDAEMIA 21 0.0018
699 SURGERY 103 0.0018
700 EYE MOVEMENT DISORDER 12 0.0018
701 FALL 583 0.0017
702 THROMBOCYTOPENIA 195 0.0017
703 BLOOD ALKALINE PHOSPHATASE INCREASED 43 0.0017
704 OFF LABEL USE 1515 0.0017
705 KNEE OPERATION 17 0.0017
706 HOSPITALISATION 264 0.0017
707 TROPONIN INCREASED 13 0.0017
708 ABORTION INDUCED 16 0.0017
709 ATRIAL SEPTAL DEFECT 14 0.0017
710 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
711 CHOLESTASIS 32 0.0017
712 INITIAL INSOMNIA 17 0.0017
713 HUNGER 23 0.0016
714 HYPERGLYCAEMIA 60 0.0016
715 EATING DISORDER 35 0.0016
716 FACIAL PARALYSIS 14 0.0016
717 BLOOD PRESSURE DECREASED 109 0.0016
718 VENTRICULAR EXTRASYSTOLES 17 0.0016
719 ULCER 26 0.0016
720 HEPATOCELLULAR INJURY 23 0.0016
721 SPLENOMEGALY 19 0.0016
722 HYSTERECTOMY 14 0.0016
723 SENSORY LOSS 13 0.0016
724 PARALYSIS 23 0.0016
725 SUBDURAL HAEMATOMA 23 0.0016
726 HYPERSOMNIA 46 0.0016
727 ERECTILE DYSFUNCTION 41 0.0016
728 LEUKOPENIA 79 0.0016
729 MATERNAL DRUGS AFFECTING FOETUS 12 0.0016
730 CARDIOMYOPATHY 23 0.0016
731 ATRIOVENTRICULAR BLOCK 12 0.0016
732 SPINAL OPERATION 19 0.0015
733 SECRETION DISCHARGE 19 0.0015
734 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
735 APHASIA 45 0.0015
736 WRONG TECHNIQUE IN DRUG USAGE PROCESS 54 0.0015
737 BLOOD SODIUM DECREASED 28 0.0015
738 HEPATIC FUNCTION ABNORMAL 55 0.0015
739 FEELING JITTERY 28 0.0015
740 HEART RATE INCREASED 144 0.0015
741 NERVE INJURY 16 0.0014
742 INCORRECT PRODUCT ADMINISTRATION DURATION 31 0.0014
743 FOOD ALLERGY 11 0.0014
744 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
745 NOCTURIA 17 0.0014
746 BLOOD POTASSIUM DECREASED 42 0.0014
747 PALLOR 38 0.0014
748 PERICARDIAL EFFUSION 32 0.0014
749 FEAR 37 0.0014
750 JAUNDICE 37 0.0014
751 SPINAL DISORDER 13 0.0014
752 URINE OUTPUT DECREASED 12 0.0014
753 DENTAL CARIES 15 0.0014
754 URINARY RETENTION 45 0.0013
755 THIRST 24 0.0013
756 QUALITY OF LIFE DECREASED 18 0.0013
757 STAPHYLOCOCCAL INFECTION 44 0.0013
758 PNEUMOTHORAX 21 0.0013
759 ADRENAL INSUFFICIENCY 16 0.0013
760 BLOOD UREA INCREASED 22 0.0013
761 PERIPHERAL COLDNESS 18 0.0013
762 JOINT INJURY 28 0.0013
763 PLATELET COUNT INCREASED 17 0.0013
764 SPEECH DISORDER 68 0.0013
765 BALANCE DISORDER 112 0.0013
766 BLOOD CREATININE INCREASED 84 0.0013
767 SEASONAL ALLERGY 18 0.0013
768 RESPIRATORY TRACT INFECTION 33 0.0013
769 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
770 MITRAL VALVE INCOMPETENCE 14 0.0012
771 VITAMIN D DEFICIENCY 12 0.0012
772 INCONTINENCE 13 0.0012
773 ANKLE FRACTURE 19 0.0012
774 HEART RATE DECREASED 43 0.0012
775 CHOLELITHIASIS 40 0.0012
776 DYSKINESIA 49 0.0012
777 BRONCHOSPASM 17 0.0012
778 ATRIAL FIBRILLATION 116 0.0012
779 PLEURAL EFFUSION 72 0.0012
780 IMPAIRED WORK ABILITY 25 0.0012
781 PRODUCT PREPARATION ERROR 24 0.0012
782 NERVOUSNESS 61 0.0012
783 OCULAR HYPERAEMIA 55 0.0012
784 HIATUS HERNIA 15 0.0012
785 OCULAR DISCOMFORT 13 0.0012
786 HYPOMAGNESAEMIA 16 0.0011
787 URINARY INCONTINENCE 34 0.0011
788 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
789 HYPERKALAEMIA 40 0.0011
790 SCRATCH 12 0.0011
791 UNEVALUABLE EVENT 86 0.0011
792 HYPONATRAEMIA 64 0.0011
793 DYSTONIA 22 0.0011
794 RENAL FAILURE 150 0.0011
795 ILEUS 14 0.0011
796 HEMIPARESIS 19 0.0011
797 ACCIDENTAL EXPOSURE TO PRODUCT 114 0.0011
798 LIMB INJURY 30 0.0011
799 MUSCULOSKELETAL DISCOMFORT 19 0.0011
800 PREMATURE BABY 33 0.0011
801 DEPENDENCE 60 0.0011
802 CORONARY ARTERY DISEASE 33 0.0011
803 DRUG INEFFECTIVE 1420 0.0011
804 NODULE 14 0.0011
805 MALNUTRITION 12 0.0011
806 BEDRIDDEN 14 0.0011
807 PHOTOPHOBIA 20 0.0011
808 SYNCOPE 106 0.0011
809 CARDIAC FAILURE 85 0.0011
810 SCAR 18 0.0011
811 FEELING ABNORMAL 243 0.0010
812 EXTRAPYRAMIDAL DISORDER 25 0.0010
813 DYSURIA 37 0.0010
814 ABSCESS 16 0.0010
815 ABORTION SPONTANEOUS 40 0.0010
816 GASTRITIS 26 0.0010
817 HERNIA 19 0.0010
818 CHROMATURIA 22 0.0010
819 NEUROTOXICITY 17 0.0010
820 COLD SWEAT 17 0.0010
821 MUSCLE TIGHTNESS 15 0.0009
822 RIB FRACTURE 19 0.0009
823 ASCITES 27 0.0009
824 THERAPEUTIC RESPONSE UNEXPECTED 41 0.0009
825 PHOTOSENSITIVITY REACTION 15 0.0009
826 VERTIGO 55 0.0009
827 RETCHING 19 0.0009
828 INCREASED APPETITE 17 0.0009
829 POLLAKIURIA 37 0.0009
830 ANHEDONIA 23 0.0009
831 SKIN LESION 24 0.0009
832 IMMUNODEFICIENCY 13 0.0009
833 HAEMORRHAGE INTRACRANIAL 13 0.0009
834 CARDIOVASCULAR DISORDER 22 0.0009
835 MELAENA 19 0.0009
836 BLOOD POTASSIUM INCREASED 14 0.0009
837 CARPAL TUNNEL SYNDROME 12 0.0009
838 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
839 NEPHROLITHIASIS 39 0.0008
840 FLUSHING 86 0.0008
841 FOOT FRACTURE 16 0.0008
842 BLOOD URINE PRESENT 16 0.0008
843 GOUT 15 0.0008
844 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
845 BRAIN FOG 13 0.0008
846 TOOTHACHE 15 0.0008
847 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
848 DERMATITIS 17 0.0008
849 PALPITATIONS 93 0.0008
850 HYPOCALCAEMIA 15 0.0008
851 BACK PAIN 184 0.0008
852 EYE DISORDER 26 0.0008
853 HAEMATURIA 27 0.0008
854 SWELLING FACE 51 0.0008
855 DIALYSIS 11 0.0008
856 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
857 DEAFNESS 20 0.0008
858 CEREBRAL HAEMORRHAGE 27 0.0008
859 BLOOD GLUCOSE DECREASED 36 0.0007
860 NEURALGIA 18 0.0007
861 PRODUCT PRESCRIBING ISSUE 16 0.0007
862 BLOOD PRESSURE INCREASED 111 0.0007
863 ACUTE MYOCARDIAL INFARCTION 21 0.0007
864 RENAL DISORDER 33 0.0007
865 DEHYDRATION 94 0.0007
866 BLOOD PRESSURE ABNORMAL 14 0.0007
867 UPPER LIMB FRACTURE 14 0.0007
868 EMOTIONAL DISTRESS 84 0.0007
869 GASTRIC ULCER 13 0.0007
870 PELVIC PAIN 12 0.0007
871 TINNITUS 30 0.0007
872 HAEMORRHAGE 68 0.0006
873 MYALGIA 108 0.0006
874 SKIN DISCOLOURATION 29 0.0006
875 TOOTH DISORDER 14 0.0006
876 LACRIMATION INCREASED 19 0.0006
877 POST PROCEDURAL COMPLICATION 12 0.0006
878 CARDIAC DISORDER 58 0.0006
879 NO ADVERSE EVENT 112 0.0006
880 HAEMATOMA 16 0.0006
881 MOUTH ULCERATION 13 0.0006
882 CEREBRAL INFARCTION 15 0.0006
883 GASTROENTERITIS VIRAL 11 0.0006
884 SPINAL FRACTURE 12 0.0006
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
886 FLATULENCE 33 0.0006
887 EPISTAXIS 43 0.0006
888 SEPTIC SHOCK 25 0.0006
889 APPLICATION SITE ERYTHEMA 15 0.0006
890 ABASIA 14 0.0006
891 SEPSIS 63 0.0006
892 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
893 HYPOTHYROIDISM 18 0.0006
894 ANGINA PECTORIS 16 0.0006
895 THROAT TIGHTNESS 15 0.0006
896 DIABETES MELLITUS 42 0.0006
897 VISUAL ACUITY REDUCED 18 0.0005
898 DRY EYE 27 0.0005
899 RENAL INJURY 16 0.0005
900 PRODUCT ADHESION ISSUE 19 0.0005
901 MYOCARDIAL INFARCTION 92 0.0005
902 RED BLOOD CELL COUNT DECREASED 15 0.0005
903 ILLNESS 54 0.0005
904 CONSTIPATION 114 0.0005
905 HOT FLUSH 39 0.0005
906 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
907 RASH MACULAR 18 0.0005
908 VIRAL INFECTION 17 0.0005
909 HYPOPHAGIA 13 0.0005
910 FAECES DISCOLOURED 11 0.0005
911 NEUROPATHY PERIPHERAL 48 0.0005
912 VISION BLURRED 69 0.0005
913 BLOOD PRESSURE FLUCTUATION 12 0.0005
914 DIABETIC KETOACIDOSIS 12 0.0005
915 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 101 0.0005
916 MOVEMENT DISORDER 16 0.0005
917 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
918 PRESYNCOPE 12 0.0005
919 ERYTHEMA 100 0.0005
920 CHILLS 57 0.0005
921 DYSSTASIA 14 0.0005
922 EXTRA DOSE ADMINISTERED 19 0.0005
923 FEELING COLD 13 0.0005
924 SKIN ULCER 12 0.0005
925 PRODUCTIVE COUGH 22 0.0005
926 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
927 ANAPHYLACTIC REACTION 25 0.0005
928 LIMB DISCOMFORT 14 0.0005
929 EYE PAIN 25 0.0004
930 CHEST DISCOMFORT 45 0.0004
931 DYSPHAGIA 41 0.0004
932 EYE SWELLING 16 0.0004
933 CHRONIC KIDNEY DISEASE 32 0.0004
934 CATARACT 25 0.0004
935 RENAL IMPAIRMENT 35 0.0004
936 THERAPY CESSATION 21 0.0004
937 BLOOD GLUCOSE INCREASED 77 0.0004
938 GASTRIC DISORDER 14 0.0004
939 RHINORRHOEA 26 0.0004
940 DEEP VEIN THROMBOSIS 26 0.0004
941 BURNING SENSATION 28 0.0004
942 DEMENTIA 11 0.0004
943 BLINDNESS 16 0.0004
944 SKIN EXFOLIATION 33 0.0004
945 PULMONARY EMBOLISM 37 0.0004
946 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
948 INFLUENZA LIKE ILLNESS 31 0.0004
949 DYSPHONIA 22 0.0004
950 DRUG EFFECT DECREASED 20 0.0004
951 LYMPHADENOPATHY 13 0.0004
952 HAEMATOCHEZIA 20 0.0004
953 EXPIRED PRODUCT ADMINISTERED 12 0.0004
954 HAEMOGLOBIN DECREASED 37 0.0004
955 DYSGEUSIA 26 0.0003
956 THROMBOSIS 28 0.0003
957 PRODUCT DOSE OMISSION ISSUE 101 0.0003
958 COLITIS 13 0.0003
959 NASAL CONGESTION 20 0.0003
960 COVID-19 59 0.0003
961 OROPHARYNGEAL PAIN 30 0.0003
962 PLATELET COUNT DECREASED 34 0.0003
963 DYSPNOEA EXERTIONAL 12 0.0003
964 CELLULITIS 16 0.0003
965 CARDIAC FAILURE CONGESTIVE 25 0.0003
966 ECZEMA 16 0.0003
967 ANAEMIA 57 0.0003
968 INCORRECT DOSE ADMINISTERED 68 0.0003
969 EYE IRRITATION 17 0.0003
970 RASH ERYTHEMATOUS 14 0.0003
971 BONE PAIN 17 0.0003
972 INFLUENZA 31 0.0003
973 URINARY TRACT INFECTION 46 0.0003
974 THROAT IRRITATION 12 0.0003
975 SKIN IRRITATION 12 0.0003
976 PANCYTOPENIA 14 0.0003
977 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
978 ANGIOEDEMA 11 0.0002
979 DRY SKIN 33 0.0002
980 HERPES ZOSTER 13 0.0002
981 INJECTION SITE ERYTHEMA 28 0.0002
982 NEOPLASM MALIGNANT 15 0.0002
983 SKIN BURNING SENSATION 16 0.0002
984 COUGH 62 0.0002
985 CEREBROVASCULAR ACCIDENT 36 0.0002
986 INJECTION SITE HAEMORRHAGE 15 0.0002
987 BREAST CANCER 16 0.0002
988 ACNE 13 0.0002
989 INJECTION SITE BRUISING 13 0.0002
990 DRUG DOSE OMISSION 25 0.0002
991 DEVICE ISSUE 13 0.0001
992 INJECTION SITE PAIN 42 0.0001
993 NEUTROPENIA 12 0.0001